IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 247 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.25 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $8,936 | -78.2% | 1,964 | -66.3% | 0.00% | – |
Q2 2023 | $41,085 | +171087.5% | 5,836 | +50.8% | 0.00% | – |
Q1 2023 | $24 | +100.0% | 3,871 | +106.3% | 0.00% | – |
Q4 2022 | $12 | -100.0% | 1,876 | -70.9% | 0.00% | -100.0% |
Q3 2022 | $60,000 | -17.8% | 6,438 | -2.7% | 0.00% | 0.0% |
Q2 2022 | $73,000 | +942.9% | 6,614 | +1459.9% | 0.00% | – |
Q1 2022 | $7,000 | 0.0% | 424 | 0.0% | 0.00% | – |
Q4 2021 | $7,000 | -65.0% | 424 | -48.3% | 0.00% | – |
Q3 2021 | $20,000 | -88.0% | 820 | -87.1% | 0.00% | -100.0% |
Q2 2021 | $166,000 | -17.8% | 6,369 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $202,000 | -31.8% | 6,369 | 0.0% | 0.00% | -50.0% |
Q4 2020 | $296,000 | +55.0% | 6,369 | +10.0% | 0.00% | 0.0% |
Q3 2020 | $191,000 | +11.7% | 5,791 | -7.3% | 0.00% | 0.0% |
Q2 2020 | $171,000 | +557.7% | 6,245 | +625.3% | 0.00% | – |
Q1 2020 | $26,000 | +36.8% | 861 | +22.8% | 0.00% | – |
Q4 2019 | $19,000 | +46.2% | 701 | 0.0% | 0.00% | – |
Q3 2019 | $13,000 | -43.5% | 701 | -26.2% | 0.00% | – |
Q2 2019 | $23,000 | +155.6% | 950 | 0.0% | 0.00% | – |
Q1 2019 | $9,000 | -18.2% | 950 | -20.8% | 0.00% | – |
Q4 2018 | $11,000 | +83.3% | 1,200 | +135.3% | 0.00% | – |
Q3 2018 | $6,000 | -33.3% | 510 | -27.1% | 0.00% | – |
Q2 2018 | $9,000 | -25.0% | 700 | 0.0% | 0.00% | – |
Q1 2018 | $12,000 | – | 700 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Perceptive Advisors | 12,201,261 | $203,150,000 | 4.07% |
Paradigm Biocapital Advisors LP | 907,428 | $15,109,000 | 4.00% |
Avoro Capital Advisors LLC | 9,125,000 | $151,931,000 | 2.77% |
Logos Global Management LP | 1,000,000 | $16,650,000 | 2.16% |
Avidity Partners Management LP | 6,043,219 | $100,620,000 | 2.10% |
Orbimed Advisors | 6,633,006 | $110,440,000 | 1.79% |
Parametrica Management Ltd | 134,679 | $2,240,000 | 1.66% |
Boxer Capital, LLC | 1,935,133 | $32,220,000 | 1.66% |
Fairmount Funds Management LLC | 389,588 | $6,487,000 | 1.53% |
Long Focus Capital Management, LLC | 705,000 | $11,738,000 | 1.51% |